Circulating Interleukin-6 concentration covaries inversely with self-reported sleep duration as a function of polymorphic variation in the glucocorticoid receptor

Brain, Behavior, and Immunity

Volumn 78, Issue , 2019, Pages 21-30

  Walsh, Catherine P ^a   Lim, Alvin ^a   Marsland, Anna L ^a   Ferrell, Robert E ^b   Manuck, Stephen B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Gene Environment Interaction; Genetics; Glucocorticoid receptor; Hypothalamic Pituitary Adrenal Axis; Inflammation; Interleukin 6; Polymorphism; rs6198; Sleep

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; BIOLOGICAL MARKER; GLUCOCORTICOID; HYDROCORTISONE; NR3C1 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BLOOD SAMPLING; BODY MASS; DNA ISOLATION; EUROPEAN; FEMALE; GENETIC VARIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; INFLAMMATION; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP TIME; SMOKING; BLOOD; GENETICS; HAPLOTYPE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SLEEP;

ADULT; ALLELES; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HAPLOTYPES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; SELF REPORT; SLEEP;

EID: 85060090092     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2019.01.002     Document Type: Article

References (69)

1. Abell, J.G., Shipley, M.J., Ferrie, J.E., Kivimäki, M., Kumari, M., Recurrent short sleep, chronic insomnia symptoms and salivary cortisol: a 10-year follow-up in the Whitehall II study. Psychoneuroendocrinology 68 (2016), 91–99.
2. Aiken, L.S., West, S.G., Reno, R.R., Multiple Regression: Testing and Interpreting Interactions. 1991, Sage, Thousand Oaks, CA.
3. Albanes, D., Conway, J.M., Taylor, P.R., Moe, P.W., Judd, J., Validation and comparison of eight physical activity questionnaires. Epidemiology 1 (1990), 65–71.
4. Ferrie, J.E., Kivimaki, M., Akbaraly, T.N., Singh-Manoux, A., Miller, M.A., Gimeno, D., et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am. J. Epidemiol. 178:6 (2013), 956–961.
5. Barnes, P.J., Glucocorticosteroids: current and future directions. Br. J. Pharmacol. 163:1 (2011), 29–43.
6. Cappuccio, F.P., D'Elia, L., Strazzullo, P., Miller, M.A., Sleep duration and all-cause mortality: A systematic review and meta-analysis of prospective studies. Sleep 33:5 (2010), 585–592.
7. Cappuccio, F.P., Cooper, D., D'elia, L., Strazzullo, P., Miller, M.A., Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur. Heart J. 32:12 (2011), 1484–1492.
8. Castro-Diehl, C., Roux, A.V.D., Redline, S., Seeman, T., Shrager, S.E., Shea, S., Association of sleep duration and quality with alterations in the hypothalamic-pituitary adrenocortical axis: The multi-ethnic study of atherosclerosis (MESA). J. Clin. Endocrinol. Metab. 100:8 (2015), 3149–3158.
9. Cohen, J., Cohen, P., West, S.G., Aiken, L.S., Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 2013, Routledge, New York, NY.
10. Cole, S.W., Social regulation of human gene expression: Mechanisms and implications for public health. Am. J. Public Health, 103(SUPPL.1), 2013.
11. Chen, X., Levine, L., Kwok, P.Y., Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res. 9:5 (1999), 492–498.
12. Chennaoui, M., Arnal, P.J., Sauvet, F., Léger, D., Sleep and exercise: a reciprocal issue?. Sleep Med. Rev. 20 (2015), 59–72.
13. Chung, C.C., Shimmin, L., Natarajan, S., Hanis, C.L., Boerwinkle, E., Hixson, J.E., Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure. J. Clin. Endocrinol. Metab. 94:1 (2009), 268–276.
14. Cumming, G., Fidler, F., Effect Sizes and Confidence Intervals. Hancock, G.R., Mueller, R.O., Stapleton, L.M., (eds.) The Reviewer's Guide to Quantitative Methods in the Social Sciences, 2010, Routledge, New York, NY, 79–91.
15. Derijk, R.H., de Kloet, E.R., Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur. J. Pharmacol. 583 (2008), 303–311.
16. Erickson, K.I., Banducci, S.E., Weinstein, A.M., MacDonald, A.W. III, Ferrell, R.E., Halder, I., Manuck, S.B., The brain-derived neurotrophic factor Val66Met polymorphism moderates an effect of physical activity on working memory performance. Psychol. Sci. 24:9 (2013), 1770–1779.
17. Falush, D., Stephens, M., Pritchard, J.K., Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:4 (2003), 1567–1587.
18. Ferrie, J.E., Shipley, M.J., Cappuccio, F.P., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 30 (2007), 1659–1666.
19. Grandner, M.A., Drummond, S.P., Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med. Rev. 11:5 (2007), 341–360.
20. Grandner, M.A., Buxton, O.M., Jackson, N., Sands-Lincoln, M., Pandey, A., Jean-Louis, G., Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 36:5 (2013), 769–779.
21. Gruys, E., Toussaint, M.J.M., Niewold, T.A., Koopmans, S.J., Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B, 6(11), 2005, 1045.
22. Guyon, A., Balbo, M., Morselli, L.L., et al. Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men. J. Clin. Endocrinol. Metab. 99 (2014), 2861–2868.
23. Halder, I., Muldoon, M.F., Ferrell, R.E., Manuck, S.B., Serotonin receptor 2A (HTR2A) gene polymorphisms are associated with blood pressure, central adiposity, and the metabolic syndrome. Metabolic Syndrome Related Disorders 5:4 (2007), 323–330.
24. Halder, I., Yang, B.Z., Kranzler, H.R., et al. Measurement of admixture proportions and description of admixture structure in different US populations. Hum. Mutat. 30:9 (2009), 1299–1309.
25. Hall, M.H., Smagula, S.F., Boudreau, R.M., Ayonayon, H.N., Goldman, S.E., Harris, T.B., Stone, K.L., Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the health, aging and body composition study. Sleep 38:2 (2015), 189–195.
26. Hall, M.H., Muldoon, M.F., Jennings, J.R., Buysse, D.J., Flory, J.D., Manuck, S.B., Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 31:5 (2008), 635–643.
27. Hauk, P.J., Hamid, Q.A., Chrousos, G.P., Leung, D.Y., Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunol. 105:4 (2000), 782–787.
28. Irwin, M.R., Olmstead, R., Carroll, J.E., Archival report sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol. Psychiatry 80:1 (2016), 40–52.
29. Irwin, M.R., Why sleep is important for health: a psychoneuroimmunology perspective. Ann. Rev. Psychol., 66, 2015.
30. Irwin, M.R., Wang, M., Campomayor, C.O., Collado-Hidalgo, A., Cole, S., Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 166:16 (2006), 1756–1762.
31. Irwin, M.R., Wang, M., Ribeiro, D., Cho, H.J., Olmstead, R., et al. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 64 (2008), 538–540.
32. Kadmiel, M., Cidlowski, J.A., Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci. 34:9 (2013), 518–530.
33. Keller, M.C., Gene×environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol. Psychiatry 75:1 (2014), 18–24.
34. Kino, T., Su, Y.A., Chrousos, G.P., Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell. Mol. Life Sci. 66:21 (2009), 3435–3448.
35. Knutson, K.L., Ryden, A.M., Mander, B.A., et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch. Intern. Med. 166 (2006), 1768–1774.
36. Kovacic, J.C., Moreno, P., Nabel, E.G., Hachinski, V., Fuster, V., Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation 123:17 (2011), 1900–1910.
37. Koeijvoets, K.C., van der Net, J.B., van Rossum, E.F., Steyerberg, E.W., Defesche, J.C., Kastelein, J.J., Lamberts, S.W.J., Sijbrands, E.J., Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia. J. Clin. Endocrinol. Metab. 93 (2008), 4902–4908.
38. Koper, J.W., van Rossum, E.F., van den Akker, E.L., Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids 92 (2014), 62–73.
39. Lewis-Tuffin, L.J., Cidlowski, J.A., The physiology of human glucocorticoid receptor β (hGRβ) and glucocorticoid resistance. Ann. N. Y. Acad. Sci. 1069 (2006), 1–9.
40. Libby, P., Ridker, P.M., Maseri, A., Inflammation and atherosclerosis. Circulation 105:9 (2002), 1135–1143.
41. Marsland, A.L., Gianaros, P.J., Abramowitch, S.M., Manuck, S.B., Hariri, A.R., Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 64 (2008), 484–490.
42. Manuck, S.B., Craig, A.E., Flory, J.D., Halder, I., Ferrell, R.E., Reported early family environment covaries with menarcheal age as a function of polymorphic variation in estrogen receptor-α. Dev. Psychopathol. 23:1 (2011), 69–83.
43. Martin, C.K., Bhapkar, M., Pittas, A.G., Pieper, C.F., Das, S.K., Williamson, D.A., Stewart, T., Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: the CALERIE 2 randomized clinical trial. JAMA internal medicine 176:6 (2016), 743–752.
44. NCBI (2017, October 6). Reference SNP Cluster Report: rs6198. Retrieved from https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6198.
45. Nicklas, B.J., You, T., Pahor, M., Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can. Med. Assoc. J. 172:9 (2005), 1199–1209.
46. Oakley, R.H., Cidlowski, J.A., Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 286:5 (2011), 3177–3184.
47. Oakley, R.H., Cidlowski, J.A., The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 132:5 (2013), 1033–1044.
48. Otte, C., Wüst, S., Zhao, S., Pawlikowska, L., Kwok, P.Y., Whooley, M.A., Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study. J. Clin. Endocrinol. Metabol. 95:6 (2010), 2885–2891.
49. O'Connor, M.F., Bower, J.E., Cho, H.J., Creswell, J.D., Dimitrov, S., Hamby, M.E., Hoyt, M.A., Martin, J.L., Robles, T.F., Sloan, E.K., Thomas, K.S., Irwin, M.R., To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 23:7 (2009), 887–897.
50. Paffenbarger, R.S. Jr, Wing, A.L., Hyde, R.T., Physical activity as an index of heart attack risk in college alumni. Am. J. Epidemiol. 108 (1978), 161–175.
51. Paffenbarger, R.S. Jr, Hyde, R.T., Wing, A.L., Lee, I.M., Jung, D.L., Kampert, J.B., The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N. Engl. J. Med. 328 (1993), 538–545.
52. Patel, S.R., Malhotra, A., Gottlieb, D.J., White, D.P., Hu, F.B., Correlates of long sleep duration. Sleep 29 (2006), 881–889.
53. Pejovic, S., Basta, M., Vgontzas, A.N., et al. Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am. J. Physiol. Endocrinol. Metab. 305 (2013), E890–E896.
54. Reynolds, A.C., Dorrian, J., Liu, P.Y., et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS ONE, 7, 2012, e41218.
55. Sallis, J.F., Haskell, W.L., Wood, P.D., Fortmann, S.P., Rogers, T., Blair, S.N., Paffenbarger, R.S. Jr, Physical activity assessment methodology in the Five-City Project. Am. J. Epidemiol. 121:1 (1985), 91–106.
56. Selvin, E., Paynter, N.P., Erlinger, T.P., The effect of weight loss on C-reactive protein: a systematic review. Arch. Intern. Med. 167:1 (2007), 31–39.
57. Szczepankiewicz, A., Leszczynska-Rodziewicz, A., Pawlak, J., Rajewska-Rager, A., Dmitrzak-Weglarz, M., Wilkosc, M., Hauser, J., Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. J. Affect. Disord. 134:1–3 (2011), 138–144.
58. Steiger, A., Holsboer, F., Neuropeptides and human sleep. Sleep 20 (1997), 1038–1052.
59. M.M. Sweitzer I. Halder J.D. Flory A.E. Craig P.J. Gianaros R.E. Ferrell S.B. Manuck Polymorphic variation in the dopamine D4 receptor predicts delay discounting as a function of childhood socioeconomic status: evidence for differential susceptibility Social Cognitive Affective Neurosci. 8 5 2013 499 508.
60. Taheri, S., Lin, L., Austin, D., et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med., 1, 2004, e62.
61. Taveras, E.M., Rifas-Shiman, S.L., Rich-Edwards, J.W., Mantzoros, C.S., Maternal short sleep duration is associated with increased levels of inflammatory markers at 3 years postpartum. Metabolism 60 (2011), 982–986.
62. Tliba, O., Cidlowski, J.A., Amrani, Y., CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the upregulation of the glucocorticoid receptor beta isoform. Mol. Pharmacol. 69:2 (2006), 588–596.
63. Van Cauter, E., Leproult, R., Kupfer, D.J., Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metabol. 81:7 (1996), 2468–2473.
64. van den Akker, E.L., Koper, J.W., van Rossum, E.F., Dekker, M.J., Russcher, H., de Jong, F.H., Lamberts, S.W., Glucocorticoid receptor gene and risk of cardiovascular disease. Arch. Intern. Med. 168:1 (2008), 33–39.
65. Vgontzas, A.N., Zoumakis, E., Bixler, E.O., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 89 (2004), 2119–2126.
66. Walker, B.R., Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157:5 (2007), 545–559.
67. Wang, E., Ding, Y.C., Flodman, P., Kidd, J.R., Kidd, K.K., Grady, D.L., Moyzis, R.K., The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am. J. Human Genetics 74:5 (2004), 931–944.
68. Webster, J.C., Oakley, R.H., Jewell, C.M., Cidlowski, J.A., Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. 98:12 (2001), 6865–6870.
69. Wong, P.M., Manuck, S.B., DiNardo, M.M., Korytkowski, M., Muldoon, M.F., Shorter sleep duration is associated with decreased insulin sensitivity in healthy white men. Sleep 38:2 (2015), 223–231.